Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 3
1989 1
1990 4
1991 5
1992 3
1993 1
1994 5
1995 6
1996 8
1997 10
1998 6
1999 4
2000 8
2001 3
2002 8
2003 6
2004 7
2005 4
2006 9
2007 10
2008 9
2009 4
2010 6
2011 16
2012 9
2013 8
2014 7
2015 33
2016 4
2017 4
2018 7
2019 11
2020 8
2021 9
2022 8
2023 4
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.
Chen DM, Odueyungbo A, Csinady E, Gearhart L, Lehane P, Cheu M, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Musette P, Joly P; French Study Group on Autoimmune Bullous Diseases. Chen DM, et al. Among authors: bedane c. Br J Dermatol. 2020 May;182(5):1111-1119. doi: 10.1111/bjd.18482. Epub 2019 Nov 28. Br J Dermatol. 2020. PMID: 31487383 Free PMC article. Clinical Trial.
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.
Tedbirt B, Maho-Vaillant M, Houivet E, Mignard C, Golinski ML, Calbo S, Prost-Squarcioni C, Labeille B, Picard-Dahan C, Chaby G, Richard MA, Tancrede-Bohin E, Duvert-Lehembre S, Delaporte E, Bernard P, Caux F, Alexandre M, Musette P, Ingen-Housz-Oro S, Vabres P, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bédane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Joly P, Hébert V; French Reference Center for Autoimmune Blistering Diseases MALIBUL. Tedbirt B, et al. Among authors: bedane c. JAMA Dermatol. 2024 Mar 1;160(3):290-296. doi: 10.1001/jamadermatol.2023.5679. JAMA Dermatol. 2024. PMID: 38265821 Free PMC article. Clinical Trial.
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.
Joly P, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Vermeulin T, Benichou J, Musette P; French study group on autoimmune bullous skin diseases. Joly P, et al. Among authors: bedane c. Lancet. 2017 May 20;389(10083):2031-2040. doi: 10.1016/S0140-6736(17)30070-3. Epub 2017 Mar 22. Lancet. 2017. PMID: 28342637 Clinical Trial.
Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris.
Tedbirt B, Houivet E, Maho-Vaillant M, Golinski ML, Calbo S, Prost-Squarcioni C, Labeille B, Picard-Dahan C, Chaby G, Richard MA, Tancrède-Bohin E, Duvert-Lehembre S, Delaporte E, Bernard P, Caux F, Alexandre M, Musette P, Ingen-Housz-Oro S, Vabres P, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bédane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Cordel N, Jeudy G, Benichou J, Hébert V, Joly P. Tedbirt B, et al. Among authors: bedane c. JAMA Dermatol. 2025 Apr 1;161(4):444-446. doi: 10.1001/jamadermatol.2024.6654. JAMA Dermatol. 2025. PMID: 40042819
[Gardasil®-induced erythema nodosum].
Longueville C, Doffoel-Hantz V, Hantz S, Souyri N, Nouaille Y, Bédane C, Sparsa A. Longueville C, et al. Among authors: bedane c. Rev Med Interne. 2012 Mar;33(3):e17-8. doi: 10.1016/j.revmed.2011.02.013. Epub 2011 Mar 23. Rev Med Interne. 2012. PMID: 21435755 French.
[Induced acne].
Bedane C, Souyri N. Bedane C, et al. Ann Dermatol Venereol. 1990;117(1):53-8. Ann Dermatol Venereol. 1990. PMID: 2138865 Review. French. No abstract available.
[Acne].
Grosshans E, Revuz J, Faure M, Roujeau JC, Bedane C. Grosshans E, et al. Among authors: bedane c. Ann Dermatol Venereol. 2002 Oct;129(10 Suppl):S182-7. Ann Dermatol Venereol. 2002. PMID: 12718149 French. No abstract available.
[Medicines shortage: Moving towards "regressive" medicine?].
Dupin N, Bédane C. Dupin N, et al. Among authors: bedane c. Ann Dermatol Venereol. 2015 Jun-Jul;142(6-7):391-2. doi: 10.1016/j.annder.2015.01.022. Epub 2015 Feb 17. Ann Dermatol Venereol. 2015. PMID: 25701097 French. No abstract available.
Erysipelas: recognition and management.
Bonnetblanc JM, Bédane C. Bonnetblanc JM, et al. Among authors: bedane c. Am J Clin Dermatol. 2003;4(3):157-63. doi: 10.2165/00128071-200304030-00002. Am J Clin Dermatol. 2003. PMID: 12627991 Review.
[Mucous membrane pemphigoid: a review].
Bédane C, Doffoel Hantz V. Bédane C, et al. Ann Dermatol Venereol. 2011 Mar;138(3):201-8. doi: 10.1016/j.annder.2011.01.012. Epub 2011 Feb 22. Ann Dermatol Venereol. 2011. PMID: 21397149 French.
243 results